Interpretable machine learning-enabled risk stratification for pulmonary arterial hypertension associated with unrepaired congenital heart disease: results from a national prospective registry

Int J Cardiol. 2026 Sep 12:134779. doi: 10.1016/j.ijcard.2026.134779. Online ahead of print.ABSTRACTBACKGROUND: Standard pulmonary arterial hypertension (PAH) risk models may not fully apply to PAH associated with unrepaired congenital heart disease (PAH-CHD). We aimed to develop and internally vali

C Chuanyong Wang

Incidence, Risk factors, and Outcomes of Thromboembolism in Patients with Melanoma Receiving Immune Checkpoint Inhibitors, Chemotherapy, or Targeted Therapy: a SEER-Medicare Analysis

J Thromb Haemost. 2026 Sep 12:S1538-7836(26)00565-9. doi: 10.1016/j.jtha.2026.09.005. Online ahead of print.ABSTRACTBACKGROUND: Little is known about venous thromboembolism (VTE) and arterial thromboembolism (ATE) risk in melanoma patients receiving immune checkpoint inhibitors (ICI), compared to ot

T Tamara A Sussman

Effects of active self-administered and receptive monochord-based sound interventions on cardiovascular parameters and patient-reported symptoms in cancer patients: an exploratory randomized crossover pilot trial

Oncol Res Treat. 2026 Sep 12:1. doi: 10.1159/ort/aecag006. Online ahead of print.ABSTRACTAim This exploratory, randomized two-period crossover pilot trial evaluated the acute effects of an active (self-administered) body monochord intervention versus a receptive monochord sound-based intervention on

A Anna Lena Hohneck